Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mesenchymal stem cell-mediated paracrine signaling refers to the process by which mesenchymal stem cells secrete bioactive molecules—such as growth factors, cytokines, chemokines, extracellular vesicles including exosomes—that act on neighboring cells. This secretion modulates immune responses by promoting anti-inflammatory macrophage polarization and regulatory T-cell induction. It also supports tissue repair through enhanced angiogenesis and inhibition of inflammatory pathways. The overall effect helps restore homeostasis in damaged tissues and has therapeutic potential in conditions like osteoarthritis and other inflammatory or degenerative diseases. The mechanism involves complex interactions between multiple secreted factors rather than targeting a single receptor or enzyme.[1][2][3]
Not applicable as this is not a drug target per se; however, mechanisms include secretion of soluble factors such as prostaglandin E2 (PGE2), indoleamine 2,3-dioxygenase (IDO), exosomes containing microRNAs and proteins that modulate immune responses and promote tissue repair.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mesenchymal stem cell-mediated paracrine signaling (MSC-mediated paracrine signaling).